1. 1) EU: EMEA/CPMP: “Position Paper on Non-clinical Safety Studies to Support Clinical Trials with a Single Microdose,” The European Medicines Agency (EMEA), Evaluation of Medicines for Human Use, CPMP/SWP/2599/02/Rev 1, London, 2004.
2. 2) US FDA: “Guidance for Industry, Investigators and Reviewers, Exploratory IND Studies,” US Department of Health and human Services, FDA, CDER, 2005.
3. 3) Oriuchi N., Higuchi T., Ishikita T., Miyakubo M., Hanaoka H., Iida Y., Endo K., Cancer Sci., 97, 1291-1297 (2006).
4. 4) Castell F., Cook G. J., Br. J. Cancer, 98, 1597-1601 (2008).
5. 5) Moresco R. M., Todde S., Belloli S., Simonelli P., Panzacchi A., Rigamonti M., Galli-Kienle M., Fazio F., Eur. J. Nucl. Med. Mol. Imaging, 32, 405-413 (2005).